Kyle Bass

Kyle Bass

Last Update: 05-16-2016

Number of Stocks: 3
Number of New Stocks: 1

Total Value: $45 Mil
Q/Q Turnover: 4%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Kyle Bass Watch

  • Kyle Bass Purchases Stake in Clovis Oncology

    During the first quarter guru Kyle Bass (Trades, Portfolio) purchased 100,000 shares of Clovis Oncology Inc. (NASDAQ:CLVS).


    Clovis Oncology is a biopharmaceutical company that is headquartered in Boulder, Colorado. The company focuses on acquiring, developing and commercializing cancer treatments in the U.S., Europe and other international markets. The company's development programs are targeted at specific subsets of cancer, combining personalized medicine with companion diagnostics to direct therapeutics to those patients who are the most likely to benefit from them.

      


  • Viacom, AutoNation Among Undervalued Guru Stocks

    According to GuruFocus' All-in-One Screener, several gurus are focusing on stocks whose Peter Lynch fair value is far above the current price. The following stocks are trading with a wide margin of safety and at least five gurus are shareholders.


    Viacom Inc. (VIAB) is trading at the price of $38, but the Peter Lynch earnings line gives the company a fair price of $69.91, giving the stock a margin of safety of 45%. It is trading with a PE ratio of 9.29 that is ranked lower than 85% of its competitors in the Global Media – Diversified industry. It is currently 47.20% below its 52-week high and 28.93% above its 52-week low.

      


  • Kyle Bass Sells Stakes in 11 Health Care Companies

    Kyle Bass (Trades, Portfolio) of Hayman Capital Management sold 11 health care-oriented stakes in the fourth quarter, the most noteworthy being the divestiture of his 606,618-share stake in Impax Laboratories Inc. (NASDAQ:IPXL), a Hayward, California-based pharmaceutical company.


    Bass sold the stake for an average price of $40.13 per share. The transaction had a -9.86% impact on Bass’ portfolio.

      


  • Lessons Learned From Kyle Bass Shorting United Development Funding

    Kyle Bass (Trades, Portfolio) is the founder and principal of Hayman Capital Management. He became well known after predicting the credit crisis of 2008 and profiting from credit default swaps and subprime mortgages.


    Bass has recently been shorting a company called United Development Funding IV (NASDAQ:UDF) because he believes it to be a Ponzi scheme. Thursday, the FBI raided the offices of United Development Funding indicating that the company has been under investigation for fraudulent activities. Shares of the company tumbled 54% as a result.

      


  • CF Industries Among Stocks Trading Below Peter Lynch Value

    According to GuruFocus' All-in-One Screener, several gurus are focusing on stocks whose Peter Lynch fair value is far above the current price. The following stocks are trading with a wide margin of safety, and at least five gurus are shareholders.


    CF Industries Holdings Inc. (CF) is trading at about $27 per share, and the Peter Lynch value gives the stock a fair price of $57.49, giving the current price a margin of safety of 53%. It is now trading with a PE ratio of 7.17, higher than 86% of companies in the Global Agricultural Inputs industry and is currently 60.97% below its 52-week high and 2.45% above its 52-week low.

      


  • Kyle Bass: China Is Running Out of Money

    Dear Investors,


    Over the past decade, we have worked diligently to identify anomalies in financial systems, governments, and companies around the world. We have been vigorously studying China over the last year, with the view that the rapid credit expansion in the Chinese banking system will result in significant credit losses that will require the recapitalization of Chinese banks and materially pressure the Chinese currency. This outcome will have many near-term and long-term effects on countries and markets around the world. In other words, what happens in China will not stay in China.

      


  • Kyle Bass on UDF: A Billion Dollar House of Cards



  • Why Kyle Bass Believes Market Will Be Down by Year-End

    Kyle Bass, founder of Hayman Capital, did an interview on Friday with CNBC where he discussed energy stocks, and why he would rather own commodities than equity. Bass also shared why he believes the U.S. market will be down between 10% to 20% by year-end.


      


  • Kyle Bass – Pessimistic On Global Economy, Bullish On Oil

    He called and profited from the subprime mortgage crisis. He nailed the European debt problems.


    Where does Kyle Bass (Trades, Portfolio) see the best opportunity in the market today?

      


  • Scott Black's 4 Stock Picks for 2016


    Guru Scott Black (Trades, Portfolio) of Delphi Management, Inc. just appeared on CNBC and talked about four of the fund's holdings. One: Apple (NASDAQ:AAPL) being a recent pick. Delphi Management pursues a proven, conservative investment strategy with a focus on fundamentals. It is rigorous with its quantitative analysis but also tries to buy into companies that are well managed. It considers itself a classic value investor of the Graham-Dodd ilk.

      


  • Pharmaceutical Stocks Hold Prominent Positions in Kyle Bass' 3rd-Quarter Activity

    Health care stocks are the most heavily weighted stocks in Kyle Bass (Trades, Portfolio)’ portfolio so it is no surprise that health care-related stocks would hold prominent positions in his third-quarter transactions.

    Bass’ most significant third-quarter transaction was the sale of his 836,593-share stake in Perrigo Co. PLC (NYSE:PRGO), a pharmaceutical company with offices in Dublin and Allegan, Mich., for an average price of $183.44 per share. The deal had a -18.25% impact on Bass’ portfolio.  


  • Kyle Bass Builds Bull Case for Clovis Oncology



  • Kyle Bass Goes Fishing for These 3 New Holdings

    Guru Kyle Bass (Trades, Portfolio) is a great investor, and I really like his investment philosophies. Most recently I read the book "Money" by Anthony Robbins, in which he interviewed Bass. He asked him, "What’s most important to winning?" and Bass replied, “Hunger and pain. Hunger comes from pain; you don’t get really hungry when it’s been easy." He then went on to say, “Luck is where preparation meets opportunity.”


    Recently Bass bought 1,281,434 shares in CF Industries Holdings Inc. (NYSE:CF), Impax Laboratories Inc. (NASDAQ:IPXL) and GW Pharmaceuticals (NASDAQ:GWPH).

      


  • Chinese Banks Will Lose All Of Their Equities - Kyle Bass

    Kyle Bass (Trades, Portfolio) believes the Chinese banking system is "too big for its britches."


    The Chinese banking system is three times the size of China's GDP. The banking system has grown four times in the past decade, and it is time for it to experience a loan loss cycle.

      


  • Kyle Bass Sees a Hard Landing for China

    Kyle Bass (Trades, Portfolio), head of Dallas-based hedge-fund Hayman Capital Management, rose to prominence in 2007 for being one of the few investors to spot the U.S. financial crisis early, and to profit from it by betting against subprime mortgages. He successfully called Japan’s banking problems (and bold monetary stimulus) a few years later, and now he’s saying China will be next.


    In an interview with Fortune prior to his appearance at this week’s Ira Sohn investing conference in San Francisco, Bass offered reasons why China’s impending banking crisis, though far bigger than the U.S. crisis in terms of the assets at risk, will have a smaller impact on the global economy. He also explained why the hedge fund business is less forgiving than it has ever been. Edited excerpts of the conversation follow.

      


  • Kyle Bass Reveals the Real Scary Problem Confronting Asia

    Kyle Bass (Trades, Portfolio) is well known for his significant macro calls on the housing bubble, European debt and Japan.


    Today he is seeing just the very start of a big cycle of nonperforming loans in Asia, especially China. There will be huge writeoffs which require massive capital injections to offset.

      


  • Broadview Advisors' Largest Buys in Q2 2015

    Broadview Advisors is a hedge fund based in Wisconsin that, on its last quarterly 13F, reported a total value of its portfolio of $948 million, with a decrease of 5.97% since the previous quarter. During Q2 2015, the firm bought 12 new stocks and increased 33 of its existing stakes. The following are the most heavily weighted buys during the quarter.


    It bought shares of Towers Watson & Co (TW) with an impact of 1.18% on its portfolio. The company is a professional services company that helps organizations improve performance through effective people, risk and financial management. It offers solutions in the areas of employee benefits, talent management, rewards, risk and capital management and healthcare exchanges for both retirees and active employees.

      


  • Kyle Bass Focuses on Fuel, Pharmaceutical Stocks in Second Quarter

    If there was a theme to Kyle Bass (Trades, Portfolio)’ investment activity in the second quarter, the founder of Dallas-based Hayman Capital Management L.P., displayed an interest in fuel and pharmaceutical stocks. Not all of Bass’ transactions fit neatly into that category, of course, but many did, including most of the largest ones.


    Bass bought 11 new stakes in the second quarter. He bought 836,593 shares of Perrigo Co. PLC (NYSE:PRGO), an Irish manufacturer of over-the-counter drugs and the most valuable stake in Bass’ portfolio, for an average price of $190.23 per share. The acquisition had an 18.25% impact on his portfolio.

      


  • Valeant Pharmaceuticals' New Female Drug

    Valeant Pharmaceuticals (NYSE:VRX) has confirmed that it will pay $1.0 billion to buy Sprout Pharmaceuticals, the closely held company that has just won U.S. approval to sell the first drug that aims to increase women 's libido. Under the terms of the agreement, which echoes The Wall Street Journal, Valeant will pay $ 500 million in cash upfront and pay the other party early next year, whose pink pills, known as “female Viagra,” will be sold under the name Addyi. The deal is scheduled to close in the third quarter.


    Other acquisitions

      


  • Kyle Bass – Stung By Losses, Hoping for a Comeback

    Not very long ago, J. Kyle Bass (Trades, Portfolio) was one of the hottest brands in the $2.5 trillion global hedge fund industry. Bass anticipated the disintegration of the nation’s mortgage market in 2008, Greece’s economic demise in 2012 and the massive bond-buying program by the Bank of Japan that began in 2013. Investments based on these insights made a mint for both himself and for clients of his $2-billion-asset Hayman Capital, which has its headquarters in Dallas. His track record of identifying global imbalances and profiting from them catapulted the unflappably confident former bond salesman into stardom.


    The investment world viewed him as a visionary who had a clear-headed plan for investing in a world where economies have been wildly distorted by artificially low interest rates. Bass’ spot-on insights also turned him into one of the investment conference circuit’s most powerful draws; and his guest appearances were coveted by business network show hosts because their audience hung on every word uttered by the brashly confident asset manager. Best-selling author Michael Lewis even profiled Bass in the opening pages of his 2011 book, “Boomerang: The Meltdown Tour.”

      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)